超声造影及MRI对非肿块型DCIS临床特征及预后的诊断效能分析  

Diagnostic Efficacy of Contrast-Enhanced Ultrasound and MRI in the Clinical Features and Prognosis of Non-Mass DCIS

作　　者：刘芳[1] 周梦红[1] 易熙 袁博[2] 欧晓霞 李莉[1] LIU Fang;ZHOU Menghong;YI Xi;YUAN Bo;OU Xiaoxia;LI Li(Department of Ultrasonic Imaging,The First Hospital of Hunan University of Chinese Medicine,Changsha Hunan 410007,China;Department of Breast Surgery,The First Hospital of Hunan University of Chinese Medicine,Changsha Hunan 410007,China;Department of Radiology,Hunan Provincial People’s Hospital(The First Affiliated Hospital of Hunan Normal University),Changsha Hunan 410016,China)

机构地区：[1]湖南中医药大学第一附属医院超声影像科,湖南长沙410007 [2]湖南中医药大学第一附属医院乳腺外科,湖南长沙410007 [3]湖南省人民医院(湖南师范大学附属第一医院)放射科,湖南长沙410016

出　　处：《中国医疗设备》2023年第9期81-86,共6页China Medical Devices

基　　金：湖南省教育厅科学研究基金项目(21C0236)。

摘　　要：目的 探讨超声造影及MRI对非肿块型乳腺导管原位癌(Ductal Carcinoma in Situ,DCIS)临床特征及预后的诊断效能。方法 选取2021年1月至2023年11月于我院行超声造影及MRI检查的100例非肿块型DCIS患者,观察并记录超声造影及MRI诊断准确率,以及其评分与临床特征及预后的关系。结果 100例患者中,超声造影检测出非肿块型DCIS83例,准确率为83.00%(83/100),MRI检测出86例,准确率为86.00%(86/100),超声造影联合MRI检测出93例,准确率为93%(93/100)。非肿块型DCIS患者病理类型、淋巴结转移、组织学分级、细胞核分级的超声评分组间有明显差异(P<0.05);非肿块型DCIS患者病理类型、淋巴结转移、组织学分级、细胞核分级的MRI评分组间有明显差异(P<0.05)。与预后良好组比较,预后不良组超声造影评分及MRI评分显著升高,组间具有统计学差异(P<0.05);超声造影检测非肿块型DCIS的曲线下面积为0.790,MRI为0.834,两者联合为0.919。结论 超声造影及MRI对非肿块型DCIS临床特征及预后具有诊断价值,且联合诊断价值更高,可用于非肿块型DCIS临床特征的鉴别诊断及预后评估。Objective To investigate the diagnostic efficacy of contrast-enhanced ultrasound and MRI in the clinical features and prognosis of non-mass ductal carcinoma in situ(DCIS).Methods A total of 100 patients with non-mass DCIS who underwent contrast-enhanced ultrasound and MRI in our hospital From January 2021 to November 2023 were selected.The diagnostic accuracy of contrast-enhanced ultrasound and MRI,and the relationship between their scores and clinical features and prognosis were observed and recorded.Results Among the 100 patients,83 cases of non-mass DCIS were detected by contrast-enhanced ultrasound,with an accuracy of 83.00%(83/100);86 cases were detected by MRI,with an accuracy of 86.00%(86/100);93 cases were detected by contrast-enhanced ultrasound combined with MRI,with an accuracy of 93%(93/100).There were significant differences in the ultrasonographic evaluation of pathological type,lymph node metastasis,histological grade and nuclear grade among the groups of non-mass DCIS patients(P<0.05).There were significant differences in MRI evaluation of pathological type,lymph node metastasis,histological grade and nuclear grade among the groups of non-mass DCIS patients(P<0.05).Compared with the good prognosis group,the contrast-enhanced ultrasound scores and MRI scores of the poor prognosis group were significantly increased,with statistical difference between the groups(P<0.05).The area under curve of non-mass DCIS detected by contrast-enhanced ultrasound was 0.790,that of MRI was 0.834,and that of the combination was 0.919.Conclusion Contrast-enhanced ultrasound and MRI have diagnostic value for the clinical features and prognosis of non-mass DCIS,and the combined diagnostic value is higher,and can be used for the differential diagnosis and prognosis evaluation of the clinical features of non-mass DCIS.

关 键 词：超声造影 MRI 非肿块型乳腺导管原位癌 临床特征 预后 

分 类 号：R737.9[医药卫生—肿瘤]